Clinical Trial Update: Dexamethasone, Ofatumumab and Bendamustine (DOT) First-line in Mantle-cell Lymphoma(MCL) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on first-line dexamethasone, ofatumumab, and bendamustine (DOT) for mantle cell lymphoma in Phase 1/2, with the trial status listed as unk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• Bendamustine (Bendamustine)
• DEXAMETHASONE (Dexamethasone)
• Ofatumumab (ofatumumab)

Snippet

Sponsor: Southern Europe New Drug Organization | Conditions: Lymphoma, Mantle-Cell | Phase 1, Phase 2 | Status: UNKNOWN